NewCo Ventures

To find out more, to out-license clinical stage molecules, or to invest in SEED Fund I, which seeds the spin-out companies contact Dr. Lorna Speid.

Prospective investors need to understand, appreciate and accept that life science investment is risky. It is not like investing in real estate, because there is a high attrition or failure rate for molecules that are in the drug development process. We use our expertise to reduce risk, but the risks are still inherent in the process. Investments cannot be refunded, and there is no guarantee of success.

For venture investors who represent cash rich governments that want to diversify their investment portfolios, your enquiries are welcomed. We are particularly interested in hearing from top tier investment groups from the Gulf States.

LSPEID@NEWCOVENTURES.ORG or by Cellphone at (858)- 531-6640

TM - Trademarks pending | ® Trademark granted